| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67877-677-84 | 67877-677 | HUMAN PRESCRIPTION DRUG | Deferasirox oral | Deferasirox oral | GRANULE | ORAL | 20200716 | N/A | ANDA | ANDA213374 | Ascend Laboratories, LLC | DEFERASIROX | 360 mg/1 | 30 PACKET in 1 CARTON (67877-677-84) / 1 GRANULE in 1 PACKET (67877-677-73) |
| 67877-676-84 | 67877-676 | HUMAN PRESCRIPTION DRUG | Deferasirox oral | Deferasirox oral | GRANULE | ORAL | 20200716 | N/A | ANDA | ANDA213374 | Ascend Laboratories, LLC | DEFERASIROX | 180 mg/1 | 30 PACKET in 1 CARTON (67877-676-84) / 1 GRANULE in 1 PACKET (67877-676-72) |
| 67877-675-84 | 67877-675 | HUMAN PRESCRIPTION DRUG | Deferasirox oral | Deferasirox oral | GRANULE | ORAL | 20200716 | N/A | ANDA | ANDA213374 | Ascend Laboratories, LLC | DEFERASIROX | 90 mg/1 | 30 PACKET in 1 CARTON (67877-675-84) / 1 GRANULE in 1 PACKET (67877-675-71) |